Perioperative Durvalumab Shows Benefits in MIBC Irrespective of pCR Status
Dato-DXd Prolongs Responses in Pretreated Advanced/Metastatic Urothelial Cancer
Updated Data Reinforce EV-302 Regimen as SOC in Advanced Urothelial Cancer
Dr Meric-Bernstam on the Efficacy and Safety of Dato-DXd in Metastatic Urothelial Cancer